Common Side Effects (Generally Mild): Temporary injection site reactions (redness, slight swelling) Mild fatigue initially (as metabolism adjusts) Occasional flushing or warmth Slight changes in appetite Contraindications and Precautions: Pregnancy or breastfeeding (insufficient safety data) Active cancer (theoretical concerns about growth pathways) Severe kidney or liver disease (requires monitoring) Hypoglycemia risk (monitor if on diabetes medications) Medical Monitoring: At The Lamkin Clinic, we monitor MOTS-C patients with: Baseline metabolic labs (glucose, HbA1c, insulin, lipids) Follow-up testing at 8-12 weeks Body composition analysis Assessment of symptoms and energy levels Adjustment of other medications as metabolism improves Important: MOTS-C should only be used under the guidance of a qualified healthcare provider experienced in peptide therapy
Takahashi K, Shibata T, Akashi-Takamura S, Kiyokawa T, Wakabayashi Y, Tanimura N, et al
Interestingly, combinational (Al + SeNP-MT 13 ) effects for amelioration of stress was optimum through Al + SeNP-MT 1 and Al + SeNP-MT 2 , whereas proved more toxic with Al + SeNP-MT 3
If the lot isnt well characterized, you cant tell whether a result reflects biology or procurement noise
Whats in the plan Built for GLP-1 Success Created specifically with GLP-1 users in mind, this plan supports critical nutrient targetsespecially protein, fiber, and hydrationwhile helping manage common medication-related challenges like appetite changes and digestive shifts
